{
    "ticker": "IPSC",
    "info": {
        "address1": "25 North 38th Street",
        "address2": "11th Floor",
        "city": "Philadelphia",
        "state": "PA",
        "zip": "19104",
        "country": "United States",
        "phone": "267 817 5790",
        "website": "https://www.centurytx.com",
        "industry": "Biotechnology",
        "industryKey": "biotechnology",
        "industryDisp": "Biotechnology",
        "sector": "Healthcare",
        "sectorKey": "healthcare",
        "sectorDisp": "Healthcare",
        "longBusinessSummary": "Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed, refractory B-cell lymphoma. The company is also involved in the development of CNTY-102, a bi-specific CD19 + CD22 CAR-iT product candidate for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-107, a Nectin-4 CAR-iT targeted product candidate for Nectin-4 positive solid tumors. In addition, it has a strategic collaboration with Bristol-Myers Squibb Company to develop and commercialize up to four iNK or iT programs, including CNTY-104, a multi-specific collaboration program targeting acute myeloid leukemia; and CNTY-106, a multi-specific collaboration program for multiple myeloma. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.",
        "fullTimeEmployees": 152,
        "companyOfficers": [
            {
                "maxAge": 1,
                "name": "Mr. Brent  Pfeiffenberger M.B.A., Pharm.D.",
                "title": "CEO & Director",
                "fiscalYear": 2023,
                "totalPay": 274065,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Adrienne  Farid Ph.D.",
                "age": 61,
                "title": "COO & Head of Early Development",
                "yearBorn": 1962,
                "fiscalYear": 2023,
                "totalPay": 670289,
                "exercisedValue": 0,
                "unexercisedValue": 509880
            },
            {
                "maxAge": 1,
                "name": "Dr. Gregory  Russotti Ph.D.",
                "age": 56,
                "title": "Chief Technology & Manufacturing Officer",
                "yearBorn": 1967,
                "fiscalYear": 2023,
                "totalPay": 852564,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Morgan  Conn Ph.D.",
                "age": 54,
                "title": "Chief Financial Officer",
                "yearBorn": 1969,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Chad A. Cowan Ph.D.",
                "title": "Chief Scientific Officer",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Kenneth J. Dow J.D.",
                "title": "Senior VP of General Counsel",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Shane  Williams Ph.D.",
                "title": "Chief People Officer",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Michael  Naso Ph.D.",
                "title": "Senior VP of Cell Engineering",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Nick  Trede M.D., Ph.D.",
                "title": "Senior VP & Head of Clinical Development",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Katja  Buhrer",
                "age": 41,
                "title": "SVP, Head of Corporate Affairs & Strategy",
                "yearBorn": 1982,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            }
        ],
        "auditRisk": 8,
        "boardRisk": 5,
        "compensationRisk": 8,
        "shareHolderRightsRisk": 8,
        "overallRisk": 7,
        "governanceEpochDate": 1730073600,
        "compensationAsOfEpochDate": 1703980800,
        "maxAge": 86400,
        "priceHint": 4,
        "previousClose": 1.36,
        "open": 1.37,
        "dayLow": 1.26,
        "dayHigh": 1.41,
        "regularMarketPreviousClose": 1.36,
        "regularMarketOpen": 1.37,
        "regularMarketDayLow": 1.26,
        "regularMarketDayHigh": 1.41,
        "beta": 1.37,
        "forwardPE": -0.69189185,
        "volume": 653349,
        "regularMarketVolume": 653349,
        "averageVolume": 340965,
        "averageVolume10days": 290900,
        "averageDailyVolume10Day": 290900,
        "bid": 1.23,
        "ask": 1.32,
        "bidSize": 100,
        "askSize": 100,
        "marketCap": 115693952,
        "fiftyTwoWeekLow": 1.26,
        "fiftyTwoWeekHigh": 5.51,
        "priceToSalesTrailing12Months": 56.684937,
        "fiftyDayAverage": 1.5853,
        "twoHundredDayAverage": 2.908775,
        "currency": "USD",
        "enterpriseValue": -31589570,
        "floatShares": 33555145,
        "sharesOutstanding": 84716000,
        "sharesShort": 3325333,
        "sharesShortPriorMonth": 3277833,
        "sharesShortPreviousMonthDate": 1726185600,
        "dateShortInterest": 1728950400,
        "sharesPercentSharesOut": 0.039300002,
        "heldPercentInsiders": 0.28461,
        "heldPercentInstitutions": 0.59103,
        "shortRatio": 9.08,
        "shortPercentOfFloat": 0.0481,
        "impliedSharesOutstanding": 90385904,
        "bookValue": 2.627,
        "priceToBook": 0.4872478,
        "lastFiscalYearEnd": 1703980800,
        "nextFiscalYearEnd": 1735603200,
        "mostRecentQuarter": 1719705600,
        "netIncomeToCommon": -131387000,
        "trailingEps": -1.89,
        "forwardEps": -1.85,
        "pegRatio": 0.05,
        "enterpriseToRevenue": -15.477,
        "enterpriseToEbitda": 0.275,
        "52WeekChange": -0.087248325,
        "SandP52WeekChange": 0.3763833,
        "exchange": "NMS",
        "quoteType": "EQUITY",
        "symbol": "IPSC",
        "underlyingSymbol": "IPSC",
        "shortName": "Century Therapeutics, Inc.",
        "longName": "Century Therapeutics, Inc.",
        "firstTradeDateEpochUtc": 1624023000,
        "timeZoneFullName": "America/New_York",
        "timeZoneShortName": "EDT",
        "uuid": "f95000f0-82eb-31c4-9606-6aa49d9bac06",
        "messageBoardId": "finmb_626518430",
        "gmtOffSetMilliseconds": -14400000,
        "currentPrice": 1.28,
        "targetHighPrice": 12.0,
        "targetLowPrice": 6.0,
        "targetMeanPrice": 10.2,
        "targetMedianPrice": 12.0,
        "recommendationMean": 1.7,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 5,
        "totalCash": 196402000,
        "totalCashPerShare": 2.318,
        "ebitda": -114721000,
        "totalDebt": 56376000,
        "quickRatio": 10.341,
        "currentRatio": 10.618,
        "totalRevenue": 2041000,
        "debtToEquity": 25.383,
        "revenuePerShare": 0.031,
        "returnOnAssets": -0.1924,
        "returnOnEquity": -0.55948,
        "freeCashflow": -62074376,
        "operatingCashflow": -97459000,
        "revenueGrowth": 6.788,
        "operatingMargins": -45.077824,
        "financialCurrency": "USD",
        "trailingPegRatio": null
    }
}